banner
Proteasome inhibitor Ixazomib citrate, Purity ≥98%

Cat. No.: X24-07-ZQ864

Proteasome inhibitor Ixazomib citrate, Purity ≥98%

Synonym: 1239908-20-3; Proteasome inhibitor; MLN9708 citrate; MLN 9708; MLN-9708

  • CAS Number: 1239908-20-3
  • Compound CID: 56844015
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Ixazomib citrate interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Weight
517.12
Molecular Formula
C20H23BCl2N2O9
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ixazomib citrate is used in research targeting the proteasome, which is responsible for degrading damaged proteins, relevant to cancer treatment.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0